Table 2.
Commonly used IBD mouse models.
| Categories | Model examples | Prevalent type of response | Details of barrier defect | References |
|---|---|---|---|---|
| Chemical induction | Dextran sodium sulfate (DSS) colitis | Epithelial damage | Deficiency of Muc2, main gastrointestinal mucin. | Persše and Cerar, 2012; Chassaing et al., 2014 |
| 2,4,6-trinitrobenzene sulfonic acid (TNBS) | Epithelial damage, immune-mediated | Coupled with intestinal proteins eliciting significant immunologic response, such as Th1 inflammatory response. | Loeuillard et al., 2014 | |
| Oxazolone | Epithelial damage, immune-mediated | Direct destruction of colonic mucosa and association with Th2-type inflammatory response. | Heller et al., 2002; Weigmann and Neurath, 2016 | |
| Spontaneous mutation | SAMP1/Yit | Immune-mediated | Spontaneous inflammation of terminal ileum and cecum driven by TH1 response and epithelial barrier defect, but TH2 response may develop at later stages of disease. | Pizarro et al., 2011 |
| C3H/HeJBir | Immune-mediated | Increased B-cell and T-cell reactivity to antigens of enteric bacterial flora causing colitis. | Elson et al., 2000 | |
| Nuclear factor κB (NF-κB) essential modulator (NEMO) colitis | Cytokine release | Reduced paneth cell numbers and increased IEC apoptosis. | Liu et al., 2017 | |
| Adoptive T-cell transfer | Systemic T-cell activation | Immune-mediated | Cytokine release (TNF, LIGHT) causing MLCK activation and occludin endocytosis. | Chen and Sundrud, 2016 |
| CD4 + CD45RBhi | Immune-mediated | CD4+ cells from diseased mice displayed highly polarized Th1 pattern of cytokine synthesis. | Byrne et al., 2005 | |
| Genetic engineering | IL-10−/− knockout | Cytokine release, epithelial damage | IL-10 signaling in macrophages and neutrophils is necessary to prevent abnormal regulation of responses to normal microflora. | Scheinin et al., 2003 |
| FOXP3 mutation | Immune-mediated | Autoimmune enteropathy by excessive T-cell activation. | Bamidele et al., 2018 | |
| Dominant negative N-cadherin transgene expression | Epithelial damage | Defective epithelial maturation, migration, and adherens junctions. | Radice, 2013 | |
| MDR1A-deficient mice | Epithelial damage | Reduced occludin phosphorylation, increased epithelial cell response to LPS. | Wilk et al., 2005 | |
| Constitutively active MLCK transgene expression | Epithelial damage | MLC hyperphosphorylation, barrier dysregulation. | Cunningham and Turner, 2012 | |
| JAM-A-deficient mice | Epithelial damage | Effect on epithelial permeability. | Laukoetter et al., 2007 | |
| Mucin-2-deficient mice | Epithelial damage | Intercellular junction defects, mitochondrial damage, and ATP depletion. | Borisova et al., 2020 | |
| Microbiome induction | Enteropathogenic Escherichia coli infection | Immune-mediated | Type III secretion (of bacterial proteins), MLCK activation, and occludin endocytosis. | Glotfelty and Hecht, 2012 |
| Clostridium difficile-induced colitis | Epithelial damage | Actomyosin disruption and glucosylation of Rho proteins, loss of ZO1 and ZO2. | Best et al., 2012 | |
| Enteric microbial transfer to germ-free IL-10−/− mice | Immune-mediated | Resident enteric bacteria are necessary for the development of spontaneous colitis and immune system activation in IL-10-deficient mice. | Keubler et al., 2015 |